Mazor Robotics (MZOR) Downgraded by BidaskClub to Buy

Mazor Robotics (NASDAQ:MZOR) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other equities analysts have also recently commented on the stock. Zacks Investment Research upgraded shares of Mazor Robotics from a “sell” rating to a “hold” rating in a research report on Thursday, November 16th. TheStreet upgraded shares of Mazor Robotics from a “d” rating to a “c-” rating in a research report on Wednesday, November 8th. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research report on Tuesday, November 7th. Ladenburg Thalmann Financial Services set a $67.00 target price on shares of Mazor Robotics and gave the stock a “buy” rating in a research report on Monday, October 30th. Finally, Barclays cut shares of Mazor Robotics from an “equal weight” rating to an “underweight” rating and decreased their target price for the stock from $55.00 to $34.00 in a research report on Thursday, October 19th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. Mazor Robotics presently has an average rating of “Hold” and an average price target of $39.83.

Shares of Mazor Robotics (MZOR) traded down $0.32 during trading hours on Friday, reaching $57.83. 310,115 shares of the company were exchanged, compared to its average volume of 547,292. Mazor Robotics has a one year low of $20.50 and a one year high of $65.97.

Several hedge funds have recently added to or reduced their stakes in MZOR. Quantbot Technologies LP purchased a new position in shares of Mazor Robotics in the second quarter valued at about $135,000. Advisor Group Inc. increased its position in shares of Mazor Robotics by 365.8% in the third quarter. Advisor Group Inc. now owns 2,795 shares of the medical instruments supplier’s stock valued at $138,000 after acquiring an additional 2,195 shares during the period. Ladenburg Thalmann Financial Services Inc. increased its position in shares of Mazor Robotics by 107.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,811 shares of the medical instruments supplier’s stock valued at $188,000 after acquiring an additional 1,973 shares during the period. JPMorgan Chase & Co. increased its position in shares of Mazor Robotics by 398.5% in the first quarter. JPMorgan Chase & Co. now owns 6,979 shares of the medical instruments supplier’s stock valued at $208,000 after acquiring an additional 5,579 shares during the period. Finally, Halbert Hargrove Russell LLC purchased a new position in shares of Mazor Robotics in the third quarter valued at about $214,000. Hedge funds and other institutional investors own 26.46% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/12/02/mazor-robotics-mzor-downgraded-by-bidaskclub-to-buy.html.

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply